Back to search
Quell Therapeutics Limited
11890040
active
ltd
england wales
Health Score
65 / 100
Some Concerns
25/30
Filing
0/30
Financial
40/40
Risk
No risk factors detected.
Details
3rd Floor, Translation & Innovation Hub, 84 Wood Lane, London, W12 0BZ
Incorporated 19/03/2019
Compliance
Last accounts
31/12/2025
full
Next accounts due
30/09/2027
On track
Confirmation statement
Last: 28/04/2026
Due 12/05/2027
On track
Industry
72110
Research and experimental development on biotechnologyOfficers
Former
Stephen Keith Rhind
director · Resigned 28/02/2021
Alberto Sanchez Fueyo
director · Resigned 24/11/2021
Houman Ashrafian
director · Resigned 15/08/2023
Martin Patrick Murphy
director · Resigned 31/12/2023
Mitre Secretaries Limited
corporate secretary · Resigned 08/03/2024
Rachel Brooke Mears
director · Resigned 31/05/2025
Persons with Significant Control
Syncona Limited
25–50% shares
25–50% votes
Arnold House, St Julian's Avenue, St. Peter Port, GY1 3RD
Reg: 55514 · Guernsey Registry · Non-Cellular Company
Notified 29/03/2019
Former PSCs
Syncona Portfolio Limited
Ceased 29/03/2019
Change History
officer appointed → RIVERS, Tyrell Jermaine
2026-06-08officer appointed → LONG-MCGIE, Jeffrey Stephen
2026-06-08officer appointed → MCGILL, Iain Robert
2026-06-08officer appointed → PATEL, Dhavalkumar D, Dr
2026-06-08officer appointed → PETRIS, Elisa Michela, Dr
2026-06-08officer appointed → BESHAR, Luke Matthew
2026-06-08officer appointed → BINGHAM, Catherine Elizabeth, Dame
2026-06-08officer appointed → CLANCY, Annette
2026-06-08officer appointed → LECHLER, Robert Ian, Sir
2026-06-08type → ltd
2026-06-08Private Limited Company
address line1 → 3rd Floor, Translation & Innovation Hub
2026-06-083RD FLOOR, TRANSLATION & INNOVATION HUB
post town → London
2026-06-08LONDON
status → active
2026-06-08Active